BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31059707)

  • 21. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
    Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
    Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii.
    Zhou J; Wang L; Lu G; Zhou A; Zhu M; Li Q; Wang Z; Arken M; Wang A; He S
    Parasite; 2016; 23():17. PubMed ID: 27055564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
    Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
    Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
    Zhao Y; Huang B; Huang S; Zheng H; Li YQ; Lun ZR; Shen J; Wang Y; Kasper LH; Lu F
    Parasitol Res; 2013 Sep; 112(9):3151-60. PubMed ID: 23783399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.
    Picchio MS; Sánchez VR; Arcon N; Soto AS; Perrone Sibilia M; Aldirico MLA; Urrutia M; Moretta R; Fenoy IM; Goldman A; Martin V
    Exp Parasitol; 2018 Feb; 185():62-70. PubMed ID: 29309783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cell activator compound 48/40 is not an effective adjuvant for UV-attenuated Toxoplasma gondii vaccine.
    Li X; Chen S; Huang S; Lu F
    Parasitol Res; 2017 Aug; 116(8):2347-2353. PubMed ID: 28573462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunostimulatory efficacy and protective potential of putative TgERK7 protein in mice experimentally infected by Toxoplasma gondii.
    Li ZY; Guo HT; Calderón-Mantilla G; He JJ; Wang JL; Bonev BB; Zhu XQ; Elsheikha HM
    Int J Med Microbiol; 2020 Jul; 310(5):151432. PubMed ID: 32654774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
    Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
    Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M; He S; Cui Y; Yao Y; Wang H
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
    Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
    Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
    Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
    BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice.
    Khodadadi M; Ghaffarifar F; Dalimi A; Ahmadpour E
    Acta Trop; 2021 Apr; 216():105836. PubMed ID: 33485872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts.
    Beghetto E; Nielsen HV; Del Porto P; Buffolano W; Guglietta S; Felici F; Petersen E; Gargano N
    J Infect Dis; 2005 Feb; 191(4):637-45. PubMed ID: 15655789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
    Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
    Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of Toxoplasma gondii in the tissues of BALB/c mice after immunization with nanoliposomal excretory-secretory antigens using Real-Time PCR.
    Azadi Y; Ahmadpour E; Hamishehkar H; Daryani A; Spotin A; Mahami-Oskouei M; Barac A; Rajabi S; Alizadeh P; Montazeri M
    Comp Immunol Microbiol Infect Dis; 2018 Aug; 59():52-56. PubMed ID: 30290888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Th17 immune responses of recombinant DNA vaccine encoding GRA14 and ROP13 genes against Toxoplasma gondii in BALB/c mice.
    Fatollahzadeh M; Eskandarian A; Darani HY; Pagheh AS; Ahmadpour E
    Infect Genet Evol; 2021 Dec; 96():105150. PubMed ID: 34801755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.